{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T21:17:10Z","timestamp":1791753430072,"version":"4.3.4"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T00:00:00Z","timestamp":1670544000000},"content-version":"vor","delay-in-days":5090,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1111\/j.1538-7836.2008.03230.x","type":"journal-article","created":{"date-parts":[[2008,11,20]],"date-time":"2008-11-20T12:26:46Z","timestamp":1227184006000},"page":"58-64","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":183,"title":["Dalteparin for the prevention of recurrence of placental-mediated complications of pregnancy in women without thrombophilia: a pilot randomized controlled trial"],"prefix":"10.1016","volume":"7","author":[{"given":"E.","family":"REY","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"GARNEAU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"DAVID","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"GAUTHIER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"LEDUC","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"MICHON","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"MORIN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"DEMERS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.R.","family":"KAHN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.A.","family":"MAGEE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"RODGER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1538-7836.2008.03230.x_bb0010","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1136\/bmj.322.7282.329","article-title":"Antiplatelet drugs for prevention of pre-eclampsia and its consequences: systematic review","volume":"322","author":"Duley","year":"2001","journal-title":"BMJ"},{"key":"10.1111\/j.1538-7836.2008.03230.x_bb0015","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/aje\/kwj218","article-title":"Periconceptional multivitamin use reduces the risk of preeclampsia","volume":"164","author":"Bodnar","year":"2006","journal-title":"Am J Epidemiol"},{"key":"10.1111\/j.1538-7836.2008.03230.x_bb0020","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ajog.2007.06.067","article-title":"Folic acid supplementation in early second trimester and the risk of preeclampsia","volume":"198","author":"Wen","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"10.1111\/j.1538-7836.2008.03230.x_bb0025","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1056\/NEJMoa054186","article-title":"Vitamins C and E and the risks of preeclampsia and perinatal complications","volume":"354","author":"Rumbold","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1538-7836.2008.03230.x_bb0030","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/S0140-6736(06)68433-X","article-title":"Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): randomised placebo-controlled trial","volume":"367","author":"Poston","year":"2006","journal-title":"Lancet"},{"key":"10.1111\/j.1538-7836.2008.03230.x_bb0035","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1093\/humrep\/15.8.1830","article-title":"Do placental lesions reflect thrombophilia state in women with adverse pregnancy outcome?","volume":"15","author":"Mousa","year":"2000","journal-title":"Hum Reprod"},{"key":"10.1111\/j.1538-7836.2008.03230.x_bb0040","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1182\/blood-2005-02-0626","article-title":"Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy","volume":"106","author":"Greer","year":"2005","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2008.03230.x_bb0045","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1161\/01.HYP.0000149950.05182.a3","article-title":"Low-molecular-weight heparin lowers the recurrence rate of preeclampsia and restores the physiological vascular changes in angiotensin-converting enzyme DD women","volume":"45","author":"Mello","year":"2005","journal-title":"Hypertension"},{"key":"10.1111\/j.1538-7836.2008.03230.x_bb0050","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1479-828X.1995.tb02141.x","article-title":"Prevention of preeclampsia with heparin and antiplatelet drugs in women with renal disease","volume":"35","author":"North","year":"1995","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1111\/j.1538-7836.2008.03230.x_bb0055","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1080\/10641950600745517","article-title":"Prophylaxis of recurrent preeclampsia: low-molecular-weight heparin plus low-dose aspirin versus low-dose aspirin alone","volume":"25","author":"Ferrazzani","year":"2006","journal-title":"Hypertens Pregnancy"},{"key":"10.1111\/j.1538-7836.2008.03230.x_bb0060","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0020-7292(00)00290-3","article-title":"Prophylaxis and treatment of thromboembolic diseases during pregnancy with dalteparin","volume":"71","author":"Rey","year":"2000","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1111\/j.1538-7836.2008.03230.x_bb0065","doi-asserted-by":"crossref","first-page":"E35","DOI":"10.1542\/peds.108.2.e35","article-title":"A new and improved population-based Canadian reference for birth weight for gestational age","volume":"108","author":"Kramer","year":"2001","journal-title":"Pediatrics"},{"key":"10.1111\/j.1538-7836.2008.03230.x_bb0070","first-page":"40","article-title":"Early fetal growth retardation: obstetric background and recurrence rate","volume":"67","author":"Visser","year":"1986","journal-title":"Obstet Gynecol"},{"key":"10.1111\/j.1538-7836.2008.03230.x_bb0075","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1016\/S0002-9378(12)90773-5","article-title":"Severe preeclampsia in the second trimester: recurrence risk and long-term prognosis","volume":"165","author":"Sibai","year":"1991","journal-title":"Am J Obstet Gynecol"},{"key":"10.1111\/j.1538-7836.2008.03230.x_bb0080","doi-asserted-by":"crossref","first-page":"549","DOI":"10.2307\/2530245","article-title":"A multiple testing procedure for clinical trials","volume":"35","author":"O\u2019Brien","year":"1979","journal-title":"Biometrics"},{"key":"10.1111\/j.1538-7836.2008.03230.x_bb0085","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.1182\/blood-2003-12-4250","article-title":"Low-molecular-weight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder","volume":"103","author":"Gris","year":"2004","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2008.03230.x_bb0090","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1161\/01.HYP.0000063146.40351.AD","article-title":"Maternal-fetal flow, negative events, and preeclampsia: role of ACE I\/D polymorphism","volume":"41","author":"Mello","year":"2003","journal-title":"Hypertension"},{"key":"10.1111\/j.1538-7836.2008.03230.x_bb0095","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/01.AOG.0000249609.04831.7c","article-title":"Mapping the theories of preeclampsia and the role of angiogenic factors: a systematic review","volume":"109","author":"Widmer","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1111\/j.1538-7836.2008.03230.x_bb0100","doi-asserted-by":"crossref","first-page":"3517","DOI":"10.1210\/jc.2007-0718","article-title":"Maternal vitamin D deficiency increases the risk of preeclampsia","volume":"92","author":"Bodnar","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1538-7836.2008.03230.x_bb0105","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/01.AOG.0000128902.84876.d4","article-title":"Effects of low-molecular-weight and unfractionated heparin on trophoblast function","volume":"104","author":"Quenby","year":"2004","journal-title":"Obstet Gynecol"},{"key":"10.1111\/j.1538-7836.2008.03230.x_bb0110","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ydbio.2003.09.026","article-title":"Heparin-binding EGF-like growth factor regulates human extravillous cytotrophoblast development during conversion to the invasive phenotype","volume":"266","author":"Leach","year":"2004","journal-title":"Dev Biol"},{"key":"10.1111\/j.1538-7836.2008.03230.x_bb0115","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1159\/000098952","article-title":"Enoxaparin reduces H2O2-induced activation of human endothelial cells by a mechanism involving cell adhesion molecules and nuclear transcription factors","volume":"79","author":"Manduteanu","year":"2007","journal-title":"Pharmacology"},{"key":"10.1111\/j.1538-7836.2008.03230.x_bb0120","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/PL00000237","article-title":"Low molecular weight heparin inhibits tumor necrosis factor alpha-induced leukocyte rolling","volume":"50","author":"Wan","year":"2001","journal-title":"Inflamm Res"},{"key":"10.1111\/j.1538-7836.2008.03230.x_bb0125","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1006\/abbi.1994.1448","article-title":"Specific heparin fractions suppress endothelin-1 production in cultured human umbilical vein endothelial cells","volume":"314","author":"Reantragoon","year":"1994","journal-title":"Arch Biochem Biophys"},{"key":"10.1111\/j.1538-7836.2008.03230.x_bb0130","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/j.ultrasmedbio.2006.05.030","article-title":"Low-molecular-weight heparin improves the performance of uterine artery Doppler velocimetry to predict preeclampsia and small-for-gestational age infant in women with gestational hypertension","volume":"32","author":"Torricelli","year":"2006","journal-title":"Ultrasound Med Biol"},{"key":"10.1111\/j.1538-7836.2008.03230.x_bb0135","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1001\/jama.292.18.2249","article-title":"First-trimester placentation and the risk of antepartum stillbirth","volume":"292","author":"Smith","year":"2004","journal-title":"JAMA"},{"key":"10.1111\/j.1538-7836.2008.03230.x_bb0140","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/S0140-6736(02)11283-9","article-title":"Pre-eclampsia and expression of heparin-binding EGF-like growth factor","volume":"360","author":"Leach","year":"2002","journal-title":"Lancet"},{"key":"10.1111\/j.1538-7836.2008.03230.x_bb0145","first-page":"271","article-title":"Placental apoptosis in preeclampsia","volume":"96","author":"Allaire","year":"2000","journal-title":"Obstet Gynecol"},{"key":"10.1111\/j.1538-7836.2008.03230.x_bb0150","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1097\/01.AOG.0000265804.09161.0d","article-title":"Circulating angiogenic factors in early pregnancy and the risk of preeclampsia, intrauterine growth restriction, spontaneous preterm birth, and stillbirth","volume":"109","author":"Smith","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1111\/j.1538-7836.2008.03230.x_bb0155","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1056\/NEJMoa031587","article-title":"Previous preterm and small-for-gestational-age births and the subsequent risk of stillbirth","volume":"350","author":"Surkan","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1538-7836.2008.03230.x_bb0160","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1093\/aje\/kwj354","article-title":"Previous preeclampsia, preterm delivery, and delivery of a small for gestational age infant and the risk of unexplained stillbirth in the second pregnancy: a retrospective cohort study, Scotland, 1992\u20132001","volume":"165","author":"Smith","year":"2007","journal-title":"Am J Epidemiol"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1538-7836.2008.03230.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622125195?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622125195?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1538-7836.2008.03230.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:48:43Z","timestamp":1761533323000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622125195"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["S1538783622125195"],"URL":"https:\/\/doi.org\/10.1111\/j.1538-7836.2008.03230.x","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1156985.617064","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.1156985.626215","asserted-by":"object"}]},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dalteparin for the prevention of recurrence of placental-mediated complications of pregnancy in women without thrombophilia: a pilot randomized controlled trial","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1538-7836.2008.03230.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}